Chemotherapy (CT) declination among patients with early-stage hormone receptor positive breast cancer (BC) and high Oncotype DX recurrence scores (RS).
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Award: G7559513957
OpenAlex ID: W4410808602